Compare InMode Ltd (INMD) vs Under Armour Inc Class A (UAA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs Under Armour Inc Class A — how do they compare? InMode Ltd trades at $14.22 (market cap $809.93M), while Under Armour Inc Class A trades at $4.92 (market cap $2.07B). The key difference: Under Armour Inc Class A is far larger — about 2.6× InMode Ltd's market cap, and InMode Ltd is trading nearer its 52-week high, Under Armour Inc Class A nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and Under Armour Inc Class A for 99 Days on average.
| INMD | UAA | |
|---|---|---|
Market Cap | $809.93M | $2.07B |
Volume | 365,490 | 12,050,442 |
Sector | Health | Consumer Cyclical |
52-Week High | $16.62 | $8.14 |
52-Week Low | $12.76 | $4.17 |
Typical Hold Time | 28 Days | 99 Days |
Enterprise Value | $313.27M | $3.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.20, up 1.36% with mixed technical signals showing bearish moving averages but neutral oscillators. The company maintains strong fundamentals with 76.52% gross margins and 20.69% net income margin, though Q1 2026 earnings missed expectations. Recent news includes product innovation with Morpheus8 Cool launch and an unsolicited acquisition offer from Steel Partners at $16.75 per share. Analyst consensus is divided with 45% buy ratings amid ongoing shareholder activism concerns.
The stock presents value opportunity with attractive valuation multiples (P/E 11.63, EV/EBITDA 4.48) but faces near-term execution risks. Key catalysts include Q3 earnings delivery and resolution of acquisition talks, while risks involve management credibility and competitive pressures in aesthetic medicine markets.
Under Armour (UAA) trades at $4.93, up 2.28% on the day, with a mixed technical outlook showing a bullish moving average signal but a neutral oscillator stance. The company reported a net loss of $201.27M in 2025, with revenue declining to $5.16B, though recent quarterly earnings have beaten expectations. Analyst consensus is a 'Hold' with a $5.79 price target, while news highlights the company's focus on product simplification and margin improvement amid softer demand.
The outlook remains challenging due to persistent revenue weakness and negative profitability, but cost discipline and international growth offer potential stabilization. Key risks include execution of the turnaround plan and competitive pressures. The stock presents a speculative opportunity for investors betting on a successful brand transformation, but requires careful risk assessment given the current financial headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About Under Armour Inc Class A
Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America and other territories. Consumers of its apparel include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. Under Armour also operates a digital fitness app called MapMyFitness. The Baltimore-based company was founded in 1996.
Read more on UAA →
